• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Deep neuromuscular blockade in radiofrequency catheter ablation may provide greater reduction in atrial fibrillation recurrence

byPaary BalakumarandAlex Chan
January 27, 2025
in Cardiology, Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Deep neuromuscular blockade in radiofrequency catheter ablation under general anesthesia reduced the atrial fibrillation recurrence rate compared to moderate neuromuscular blockade 

Evidence Rating Level: 1 (Excellent)

This randomized controlled trial investigated the impact of neuromuscular blockade depth on atrial fibrillation (AF) recurrence following radiofrequency catheter ablation (RFCA) under general anesthesia. The study compared moderate (Group M) and deep (Group D) neuromuscular blockade in 94 patients over a 12-month follow-up. Both groups underwent RFCA with standardized anesthesia protocols, differing only in the intensity of muscle relaxation monitored via train-of-four and post-tetanic counts. Key outcomes included the recurrence rates of AF and related symptoms, assessed through electrocardiographic diagnosis and clinical evaluations. There was a significant reduction in AF recurrence in Group D (25%) compared to Group M (46%), with a relative risk of 0.545. Symptom recurrence rates mirrored this trend, being notably lower in the deep blockade group (25% vs. 54%, p=0.003). Additionally, procedural stability and operator satisfaction were higher in the deep blockade group due to minimized diaphragmatic movements and improved catheter contact. However, no significant differences were observed in anesthesia or ablation durations. This suggests that deep neuromuscular blockade enhances RFCA efficacy by providing a stable surgical environment, leading to lower AF recurrence rates. This research underscores the importance of precise anesthetic management in optimizing RFCA outcomes and calls for further studies to confirm these results and explore long-term implications.

Click to read the study in PLOSONE

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

Tags: atrial fibrillationcardiologyelectrophysiologyinterventional cardiologyneurology
Previous Post

Roux-en-Y gastric bypass and sleeve gastrectomy may be equally cost-effective among patients with type 2 diabetes

Next Post

Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

March 24, 2026
Chronic Disease

α-synuclein pathology is associated with faster tau accumulation in women

March 13, 2026
Next Post
Adalimumab aids in control of noninfectious uveitis

Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

2 Minute Medicine Rewind February 3, 2025

UTI associated with increased risk of preeclampsia

Blood pressure readings remain consistent in noisy and public settings

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Drying prior to plastic wrapping may not provide thermoregulatory benefits in infants admitted to the neonatal intensive care unit
  • Brown University study warns of systemic ethical risks in artificial intelligence therapy chatbots
  • Maternal smoking is associated with increased risk of sudden unexpected infant death
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.